Release Date: 31/03/11 08:30 Summary: PRE CONVERSION NOTICE TO OPTION HOLDERS Price Sensitive: No Download Document 64.12KB Download
TLX Telix gets its foot in the FDA door bringing prostate cancer detection closer to neglected Americans
Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market